Patent 6598603 Issued on July 29, 2003. Estimated Expiration Date: December 23, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
128/200.24, RESPIRATORY METHOD OR DEVICE128/200.14, LIQUID MEDICAMENT ATOMIZER OR SPRAYER128/203.12Means for mixing treating agent with respiratory gas
The invention provides a novel method of treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer.
Other References
International Patient Package Leaflet for Pulmicort.RTM. suspension for nebulisation 0.125 mg/ml, 0.25 mg/ml and 0.5 mg/ml, ASTRA, approved by Thor-Bjorn Conradson, Aug. 18, 1994 version, pp. 1-8
Dunn et al., "Inhaled Corticosteroids in Severe Bronchopulmonary Dysplasia (BPD)," No. 1263, Pediatric Research 25 (4 Part 2):213A, 1989
Dunn et al., "Nebulized Steroids for Bronchopulmonary Dysplasia (BPD)-A Randomised, Double-Blind Cross-Over Study," Pediatr. Res. 31 (4 pt 2):201A, 1992
Georgitis, "A Study of Once-A -Day Budesonide Nebulizing Suspension (BNS) and Placebo (PBO) in Asthmatic Children Aged Six Months to Eight Years," Chest 112(3):37S, Sep. 1997 Supplement
Goodwin, "An uncontrolled assessment of nebulised budesonide in the treatment of acute infantile bronchiolitis," British Journal of Clinical Research 6:113-119, 1995
Husby et al., "Treatment of croup with neublised steroid (budesonide): a double blind, placebo controlled study," Archives of Disease in Childhood 68:352-355, 1993
Jonasson et al., #P1441 "Clinical efficacy of a low dose inhaled budesonide in children with mild asthma previously not treated with steroids," The European Respiratory Journal 10(25):221s-222s, 1997
McCarthy, "Use of `Nebuhaler` and face-mask in young asthmatic children," The Lancet 335:983-984, 1990
McCarthy, "The use of a once daily inhaled glucocorticosteroid (budesonide) in the management of childhood asthma," British Jounal of Clinical Research 4:55-61, 1993
Moller et al., #0778 "Administration of Budesonide Via Turbuhaler.RTM. . . . in Children with Asthma," Eur.Respir.J. 9(23):115s, 1996
Morice et al., "A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease," Clinical Pharmacology & Therapeutics 60:675-678, 1996
Pearlman, P42 "HPA-Axis Function in Asthmatic Infants & Young Children Treated with Budesonide Nebulizing Suspension (BNS) or Placebo (PBO) Once-A-Day (QD)," Annual Meeting ACAAI, San Diego, CA (USA) Nov. 7-12, 1997
Reijonen et al., "Anti-inflammatory Therapy Reduces Wheezing After Bronchiolitis," Arch Pediatr. Adolesc. Med. 150:512-517, 1996
Takao et al., "Effects of Inhaled Nebulized Steroids (Budesonide) on Acute and Chronic Lung Function in Heart-Lung Transplant Patients," Transplantation Proceedings 27:1284-1285, 1995
Weiner et al., "Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma," Thorax 50:1270-1273, 1995
de Blic et al., "Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study", J. Allergy Clin. Immunol. 98:14-20, 1996
Godrey et al., "Nebulised Budesonide in Severe Infantile Asthma", The Lancet, II:851-852, 1987
Grimfeld, "Long-term Study of Nebulised Budesonide in Young Children With Moderate to Severe Asthma", Eur. Resp. J., 7:27s, 1994
Ilangovan et al., "Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension", Archives of Disease in Childhood, 68:356-359, 1993
Vikre-Jorgensen et al., "Dose Titration of Nebulized Budesonide in Young Children", Pediatric Pulmonology, 23:270-277, 1997
Pedersen et al., "Budesonide suspension for nebulisation in children with asthma", Eur. Respir. J., 2(Suppl. 8):647S, 1989
Volovitz et al., "Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes", J. Allergy Clin. Immunol. 101:464-469, 1998
Wennergren et al., "Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers", Acta Paediatr, 85:183-189, 199
December 23, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
